Our therapeutic areas

Improving the health of millions of people around the world

2.5 million patients treated with our medicines in 2023

Neuroscience

Multiple sclerosisNeuropsychiatry
A neurodegenerative disease with many faces

Juvisé Pharmaceuticals is committed to helping patients with relapsing-remitting multiple sclerosis.

Find out more
You are not alone in dealing with your mental health problems

Chronic depression, anxiety disorders, bipolar disorders, schizophrenia.

Find out more

Gastroenterology

Fighting Helicobacter pylori infection

Since 2022, Juvisé Pharmaceuticals has been engaged in the fight against H. pylori infection, one of the most common chronic infections, affecting around 50% of the world’s population.

Find out more

Other therapeutic areas

Oncology

Cardiology

Rheumatology

JUV-FRA-202408-0213, 09/2024